Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 467
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT02695498 Mindfulness and Mechanisms of Pain Processing in Adults With Migraines |
Mindfulness and Mechanisms of Pai… | Migraine | Non applicable | COMPLETED | En attente / non publié | Wake Forest University Health Sci… | United States · Wake Forest University Health Science… | 2016-08-26 → 2019-07-17 | Ouvrir |
| NCT06244823 The FreMRI Study: Advanced MRI on Migraine Patients Treated With Freman… |
Fremanezumab Prefilled Syringe | Migraine | Phase 4 | UNKNOWN | En attente / non publié | Hospital Clínico Universitario de… | Spain · Hospital Clinico Universitario de Valladolid,… | 2023-03-01 → 2025-01-01 | Ouvrir |
| NCT06245902 ANODYNE-1 — An Acute Migraine Factorial Study |
Naltrexone and Acetaminophen | Migraine | Phase 2 | COMPLETED | En attente / non publié | Allodynic Therapeutics, Inc | United States · Annette C. Toledano MD, North Miami, … | 2017-02-18 → 2018-02-08 | Ouvrir |
| NCT06046508 Migraine With Aura and Patent Foramen Ovale: Identification of Biomarke… |
Migraine With Aura and Patent For… | Migraine | À vérifier | UNKNOWN | En attente / non publié | Centro Cardiologico Monzino | Italy · Azienda Ospedaliera Universitaria "Federico I… | 2023-05-18 → 2025-04 | Ouvrir |
| NCT06267664 Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (T… |
Patients with migraine treated wi… | Migraine | À vérifier | UNKNOWN | En attente / non publié | Hospital Clínico Universitario de… | Spain · Hospital Clinico Universitario de Valladolid,… | 2023-12-04 → 2024-12-01 | Ouvrir |
| NCT05416476 ATEM — Anisodine Hydrobromide For The Preventive Treatment Of Episodic … |
Anisodine Hydrobromide | Migraine | Phase 3 | UNKNOWN | En attente / non publié | Second Affiliated Hospital, Zheji… | China · Dongyang People's Hospital, Dongyang, China |… | 2023-10-30 → 2025-12-31 | Ouvrir |
| NCT03194555 The Preventive Treatment of Migraine With Low-Dose Naltrexone and Aceta… |
Low-Dose Naltrexone and Acetamino… | Migraine | Phase 2 | COMPLETED | En attente / non publié | Allodynic Therapeutics, Inc | United States · Annette Toledano, M.D., North Miami, … | 2017-08-25 → 2018-07-28 | Ouvrir |
| NCT03521193 LEARNER — pLatelEts And MigRaine iN patEnt foRamen Ovale |
patent foramen ovale closure | Migraine | Non applicable | COMPLETED | En attente / non publié | Centro Cardiologico Monzino | Italy · Centro Cardiologico Monzino, IRCCS, Milan, It… | 2018-02-15 → 2020-10-31 | Ouvrir |
| NCT01004263 A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long… |
rizatriptan benzoate | Migraine | Phase 3 | COMPLETED | En attente / non publié | Antonios Likourezos | Non communiqué | 2009-12-01 → 2011-04-18 | Ouvrir |
| NCT00894556 A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Tr… |
rizatriptan | Migraine | Phase 3 | COMPLETED | En attente / non publié | Organon and Co | Non communiqué | 2009-06-10 → 2010-01-12 | Ouvrir |
| NCT03301441 SAMCO-MIG — Sensitivity to Acute Cerebral Ischemia in Migrainers |
SAMCO-MIG — Sensitivity to Acute … | Migraine | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Montpellier | France · CHU de Montpellier - Neurology Departement, … | 2018-02-09 → 2024-07 | Ouvrir |
| NCT05750446 Effect of Riocigaut on Migraine Attack Induction in People With Migraine |
Riociguat (BAY 63-2521) | Migraine | Non applicable | COMPLETED | En attente / non publié | Danish Headache Center | Denmark · Danish Headache Center, Copenhagen, Denmark | 2023-06-01 → 2024-02-01 | Ouvrir |
| NCT05484349 TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME） |
Tizanidine Hydrochloride | Migraine | Phase 3 | UNKNOWN | En attente / non publié | Second Affiliated Hospital, Zheji… | China · Affiliated Hospital of Shaoxing University, S… | 2023-06-01 → 2025-12-25 | Ouvrir |
| NCT06562400 SPHERA_WP2 — Searching for Novel Therapeutic Approaches in Migraine Pat… |
SPHERA_WP2 — Searching for Novel … | Migraine | À vérifier | RECRUITING | En attente / non publié | IRCCS National Neurological Insti… | Italy · Headache Science & Neurorehabilitation Unit, … | 2023-05-10 → 2026-05 | Ouvrir |
| NCT06549270 SPHERA_WP1_1 — Biochemical Profiling of Migraine Patients |
MAbs | Migraine | À vérifier | RECRUITING | En attente / non publié | IRCCS National Neurological Insti… | Italy · Headache Science & Neurorehabilitation Unit, … | 2023-05-10 → 2026-05 | Ouvrir |
| NCT06599905 Pain Control in Episodic and Chronic Migraine |
Pain Control in Episodic and Chro… | Migraine | Non applicable | COMPLETED | En attente / non publié | IRCCS National Neurological Insti… | Italy · Clinical Trial Center, Pavia, Italy | 2021-06-15 → 2024-04-15 | Ouvrir |
| NCT04825678 A Study to Evaluate Treatment Satisfaction With Erenumab in Participant… |
Erenumab | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | United States · ActivMed Practices and Research, LLC,… | 2021-06-11 → 2023-09-28 | Ouvrir |
| NCT06051604 Mi-Helper Transnasal Cooling for Acute Treatment of Migraine |
Mi-Helper | Migraine | Non applicable | COMPLETED | En attente / non publié | Mi-Helper, Inc. | United States · ObvioHealth, New York, United States | 2023-11-15 → 2024-09-24 | Ouvrir |
| NCT05264129 TANDEM — Study to Assess Adverse Events When Ubrogepant Tablets in Comb… |
Atogepant | Migraine | Phase 4 | COMPLETED | En attente / non publié | AbbVie | United States · Abington Neurological Associates - Ab… | 2022-03-07 → 2023-04-04 | Ouvrir |
| NCT04084314 APOLLON — Assessment of Prolonged Safety and tOLerability of in Migrain… |
Erenumab | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | Germany · Novartis Investigative Site, Aachen, German… | 2019-09-30 → 2023-03-13 | Ouvrir |
| NCT06692088 "Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing… |
"Longitudinal Analysis of Amylin … | Migraine | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Fundación Marques de Valdecilla | Non communiqué | 2025-03-01 → 2026-12-31 | Ouvrir |
| NCT04628429 CGRP-1 — CGRP Inhibition, Autonomic Function, and Migraine |
Erenumab | Migraine | À vérifier | RECRUITING | En attente / non publié | Amgen | Austria · Medical University of Vienna, Vienna, Austr… | 2020-10-01 → 2026-12 | Ouvrir |
| NCT06764914 NAMIKOS — Integrative and Complementary Therapy for Episodic Migraine a… |
NAMIKOS — Integrative and Complem… | Migraine | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Kliniken Essen-Mitte | Non communiqué | 2025-01-01 → 2031-01-01 | Ouvrir |
| NCT06751732 Craniocervical Flexion Training for Reducing Migraine Headaches and Dis… |
Craniocervical Flexion Training f… | Migraine | Non applicable | COMPLETED | En attente / non publié | Riphah International University | Pakistan · Riphah Rehab Training and Research Center,… | 2024-07-15 → 2025-02-01 | Ouvrir |
| NCT06882122 ATOM — Neurophysiological and Biomolecular Effects of Atogepant in Epis… |
Atogepant 60 mg | Migraine | À vérifier | RECRUITING | En attente / non publié | Fundación de Investigación Bioméd… | Italy · Headache Science & Neurorehabilitation Center… | 2024-12-01 → 2026-04 | Ouvrir |